Do you suffer from rosacea? Have you been covering up your persistent facial redness with makeup instead of treating it? You are not alone. Rosacea is a common, inflammatory skin condition that affects an estimated 16 million Americans and facial redness is the most widely experienced rosacea symptom.
I’m lucky to have never experienced rosacea, but a few of my close friends have so I know how frustrating this skin condition can be. Here’s the good news: now you can let go of concealers and cover-ups and get your rosacea redness under control with MIRVASO.
MIRVASO® (brimonidine) topical gel, 0.33% is the first and only FDA-approved medication developed and indicated to treat the persistent facial redness of rosacea. MIRVASO doesn’t just cover up the red; it keeps redness away for up to 12 hrs.
MIRVASO is hosting the Break Up With Your Makeup Sweepstakes to help women understand that they can treat their persistent facial redness rather than struggling to hide it with makeup and feel comfortable in their own skin again. Check it out here for more information, and enter to win a trip to the 2014 Emmy Awards!
Important Safety Information
Indication: Mirvaso® (brimonidine) topical gel, 0.33% is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.”